|
gptkbp:instance_of
|
gptkb:biotechnology
|
|
gptkbp:acquisition
|
gptkb:Zymeworks
gptkb:Ionis_Pharmaceuticals
|
|
gptkbp:ceo
|
gptkb:Michel_Vounatsos
|
|
gptkbp:clinical_trial
|
gptkb:amyotrophic_lateral_sclerosis
gptkb:muscular_dystrophy
gptkb:neurodegenerative_diseases
Amyotrophic lateral sclerosis (ALS)
|
|
gptkbp:conducts_research_on
|
gptkb:Alfred_Sandrock
|
|
gptkbp:employees
|
Over 7,000
7,000 (2021)
|
|
gptkbp:focus
|
gptkb:muscular_dystrophy
gptkb:neurodegenerative_diseases
gptkb:multiple_sclerosis
Neuroscience
neurological diseases
|
|
gptkbp:founded
|
gptkb:1978
|
|
gptkbp:founder
|
gptkb:M._Keith_Bradsher
gptkb:M._A._(Marty)_Houghton
|
|
gptkbp:head_of_commercial
|
gptkb:Jim_Mullen
|
|
gptkbp:head_of_state
|
gptkb:David_A._Mott
Michael Ehlers
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
Cambridge, Massachusetts, USA
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Biogen
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:partnership
|
gptkb:Incyte_Corporation
gptkb:Samsung_Bio_Logics
gptkb:Genentech
gptkb:Samsung_Bioepis
gptkb:Takeda_Pharmaceutical_Company
gptkb:Acorda_Therapeutics
gptkb:Alnylam_Pharmaceuticals
gptkb:Merck_KGa_A
gptkb:Astra_Zeneca
gptkb:Sanofi
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Regeneron_Pharmaceuticals
gptkb:Horizon_Therapeutics
gptkb:Sangamo_Therapeutics
gptkb:Roche
gptkb:Amgen
gptkb:Gilead_Sciences
gptkb:Eisai
gptkb:Vertex_Pharmaceuticals
gptkb:Abb_Vie
gptkb:Celgene
gptkb:Sarepta_Therapeutics
gptkb:Cure_Vac
gptkb:Novartis
|
|
gptkbp:products
|
gptkb:Rituximab
gptkb:Nusinersen
gptkb:Aducanumab
neurological therapies
multiple sclerosis therapies
|
|
gptkbp:research_focus
|
gptkb:neurodegenerative_diseases
pain management
neuromuscular diseases
psychiatric disorders
|
|
gptkbp:revenue
|
$13.45 billion (2020)
$10.5 billion (2021)
$11.4 billion (2020)
|
|
gptkbp:service_area
|
Global
|
|
gptkbp:stock_symbol
|
gptkb:BIIB
|
|
gptkbp:subsidiary
|
gptkb:Biogen_MA_Inc.
gptkb:Biogen_Idec
gptkb:Biogen_International_Gmb_H
|
|
gptkbp:technology
|
Biologics
|
|
gptkbp:traded_on
|
gptkb:NASDAQ
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
www.biogen.com
biogen.com
|
|
gptkbp:bfsParent
|
gptkb:W3_C
|
|
gptkbp:bfsLayer
|
3
|